Cargando…

Differential Activation of NRF2 Signaling Pathway in Renal-Cell Carcinoma Caki Cell Lines

Renal-cell carcinoma (RCC) is a heterogeneous disease consisting of several subtypes based on specific genomic profiles and histological and clinical characteristics. The subtype with the highest prevalence is clear-cell RCC (ccRCC), next is papillary RCC (pRCC), and then chromophobe RCC (chRCC). Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hitefield, Naomi L., Mackay, Stephen, Hays, Lauren E., Chen, Shimin, Oduor, Ian O., Troyer, Dean A., Nyalwidhe, Julius O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135738/
https://www.ncbi.nlm.nih.gov/pubmed/37189628
http://dx.doi.org/10.3390/biomedicines11041010
_version_ 1785032051023413248
author Hitefield, Naomi L.
Mackay, Stephen
Hays, Lauren E.
Chen, Shimin
Oduor, Ian O.
Troyer, Dean A.
Nyalwidhe, Julius O.
author_facet Hitefield, Naomi L.
Mackay, Stephen
Hays, Lauren E.
Chen, Shimin
Oduor, Ian O.
Troyer, Dean A.
Nyalwidhe, Julius O.
author_sort Hitefield, Naomi L.
collection PubMed
description Renal-cell carcinoma (RCC) is a heterogeneous disease consisting of several subtypes based on specific genomic profiles and histological and clinical characteristics. The subtype with the highest prevalence is clear-cell RCC (ccRCC), next is papillary RCC (pRCC), and then chromophobe RCC (chRCC). The ccRCC cell lines are further subdivided into prognostic expression-based subtypes ccA or ccB. This heterogeneity necessitates the development, availability, and utilization of cell line models with the correct disease phenotypic characteristics for RCC research. In this study, we focused on characterizing proteomic differences between the Caki-1 and Caki-2 cell lines that are commonly used in ccRCC research. Both cells are primarily defined as human ccRCC cell lines. Caki-1 cell lines are metastatic, harboring wild-type VHL, whereas Caki-2 are considered as the primary ccRCC cell lines expressing wild-type von Hippel–Lindau protein (pVHL). Here, we performed a comprehensive comparative proteomic analysis of Caki-1 and Caki-2 cells using tandem mass-tag reagents together with liquid chromatography mass spectrometry (LC/MS) for the identification and quantitation of proteins in the two cell lines. Differential regulation of a subset of the proteins identified was validated using orthogonal methods including western blot, q-PCR, and immunofluorescence assays. Integrative bioinformatic analysis identifies the activation/inhibition of specific molecular pathways, upstream regulators, and causal networks that are uniquely regulated and associated with the two cell lines and RCC subtypes, and potentially the disease stage. Altogether, we have identified multiple molecular pathways, including NRF2 signaling, which is the most significantly activated pathway in Caki-2 versus Caki-1 cells. Some of the differentially regulated molecules and signaling pathways could serve as potential diagnostic and prognostic biomarkers and therapeutic targets amongst ccRCC subtypes.
format Online
Article
Text
id pubmed-10135738
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101357382023-04-28 Differential Activation of NRF2 Signaling Pathway in Renal-Cell Carcinoma Caki Cell Lines Hitefield, Naomi L. Mackay, Stephen Hays, Lauren E. Chen, Shimin Oduor, Ian O. Troyer, Dean A. Nyalwidhe, Julius O. Biomedicines Article Renal-cell carcinoma (RCC) is a heterogeneous disease consisting of several subtypes based on specific genomic profiles and histological and clinical characteristics. The subtype with the highest prevalence is clear-cell RCC (ccRCC), next is papillary RCC (pRCC), and then chromophobe RCC (chRCC). The ccRCC cell lines are further subdivided into prognostic expression-based subtypes ccA or ccB. This heterogeneity necessitates the development, availability, and utilization of cell line models with the correct disease phenotypic characteristics for RCC research. In this study, we focused on characterizing proteomic differences between the Caki-1 and Caki-2 cell lines that are commonly used in ccRCC research. Both cells are primarily defined as human ccRCC cell lines. Caki-1 cell lines are metastatic, harboring wild-type VHL, whereas Caki-2 are considered as the primary ccRCC cell lines expressing wild-type von Hippel–Lindau protein (pVHL). Here, we performed a comprehensive comparative proteomic analysis of Caki-1 and Caki-2 cells using tandem mass-tag reagents together with liquid chromatography mass spectrometry (LC/MS) for the identification and quantitation of proteins in the two cell lines. Differential regulation of a subset of the proteins identified was validated using orthogonal methods including western blot, q-PCR, and immunofluorescence assays. Integrative bioinformatic analysis identifies the activation/inhibition of specific molecular pathways, upstream regulators, and causal networks that are uniquely regulated and associated with the two cell lines and RCC subtypes, and potentially the disease stage. Altogether, we have identified multiple molecular pathways, including NRF2 signaling, which is the most significantly activated pathway in Caki-2 versus Caki-1 cells. Some of the differentially regulated molecules and signaling pathways could serve as potential diagnostic and prognostic biomarkers and therapeutic targets amongst ccRCC subtypes. MDPI 2023-03-24 /pmc/articles/PMC10135738/ /pubmed/37189628 http://dx.doi.org/10.3390/biomedicines11041010 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hitefield, Naomi L.
Mackay, Stephen
Hays, Lauren E.
Chen, Shimin
Oduor, Ian O.
Troyer, Dean A.
Nyalwidhe, Julius O.
Differential Activation of NRF2 Signaling Pathway in Renal-Cell Carcinoma Caki Cell Lines
title Differential Activation of NRF2 Signaling Pathway in Renal-Cell Carcinoma Caki Cell Lines
title_full Differential Activation of NRF2 Signaling Pathway in Renal-Cell Carcinoma Caki Cell Lines
title_fullStr Differential Activation of NRF2 Signaling Pathway in Renal-Cell Carcinoma Caki Cell Lines
title_full_unstemmed Differential Activation of NRF2 Signaling Pathway in Renal-Cell Carcinoma Caki Cell Lines
title_short Differential Activation of NRF2 Signaling Pathway in Renal-Cell Carcinoma Caki Cell Lines
title_sort differential activation of nrf2 signaling pathway in renal-cell carcinoma caki cell lines
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135738/
https://www.ncbi.nlm.nih.gov/pubmed/37189628
http://dx.doi.org/10.3390/biomedicines11041010
work_keys_str_mv AT hitefieldnaomil differentialactivationofnrf2signalingpathwayinrenalcellcarcinomacakicelllines
AT mackaystephen differentialactivationofnrf2signalingpathwayinrenalcellcarcinomacakicelllines
AT hayslaurene differentialactivationofnrf2signalingpathwayinrenalcellcarcinomacakicelllines
AT chenshimin differentialactivationofnrf2signalingpathwayinrenalcellcarcinomacakicelllines
AT oduoriano differentialactivationofnrf2signalingpathwayinrenalcellcarcinomacakicelllines
AT troyerdeana differentialactivationofnrf2signalingpathwayinrenalcellcarcinomacakicelllines
AT nyalwidhejuliuso differentialactivationofnrf2signalingpathwayinrenalcellcarcinomacakicelllines